Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition

Psychology, Health & Medicine
Liesbeth ClaassenDanielle Timmermans

Abstract

This study compares and explains differences in perceptions of cardiovascular disease (CVD) risk and preventive behaviors in people with and without a known genetic predisposition to CVD. A cross-sectional study using two samples was performed. The first sample (genetic predisposition; n = 51) consisted of individuals recently diagnosed with familial hypercholesterolemia (FH) through DNA testing. The second sample (no genetic predisposition; n = 49) was recruited among patients with CVD-risk profiles based on family history of CVD, cholesterol levels, and blood pressure, registered at general practices. Participants filled out a postal questionnaire asking about their perceived risk, causal attributions (i.e. genetic and lifestyle), and about perceived efficacy and adoption of preventive behavior (i.e. medication adherence and adoption of a healthy diet and being sufficiently active). Perceived comparative risk, genetic attributions of CVD, and perceived efficacy of medication were higher in the "genetic predisposition" sample than in the "no genetic predisposition" sample. The samples did not differ on lifestyle attributions, efficacy of a healthy lifestyle, or preventive behavior. Individual differences in perceived risk, gen...Continue Reading

References

Jan 1, 1992·Human Mutation·H H HobbsJ L Goldstein
Jan 1, 1991·American Heart Journal·K M AndersonW B Kannel
Dec 21, 2002·American Journal of Medical Genetics. Part a·M C van MaarleG J Bonsel
Jun 6, 2003·European Heart Journal·R M ConroyUNKNOWN SCORE project group
Aug 14, 2003·Preventive Medicine·Guy H MontgomeryDana H Bovbjerg
Sep 11, 2003·European Heart Journal·Guy De BackerUNKNOWN Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
Jun 25, 2004·American Journal of Medical Genetics. Part a·Theresa MarteauUNKNOWN Genetic Risk Assessment for FH Trial Study Group
Aug 24, 2004·American Journal of Epidemiology·Melissa A AustinSteve E Humphries
Sep 10, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Margaret E McCuskerMuin J Khoury
Dec 29, 2005·JAMA : the Journal of the American Medical Association·Joanne M MurabitoChristopher J O'Donnell
Mar 10, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·Jo C PhelanRosangely Cruz-Rojas
Jun 6, 2008·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Avishay ElisMichael Lishner
Mar 11, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Louise S AchesonUNKNOWN Family Healthware Impact Trial (FHITr) Group

❮ Previous
Next ❯

Citations

Dec 9, 2017·Nature Reviews. Disease Primers·Joep C DefescheAnthony S Wierzbicki
Oct 30, 2015·Circulation·Samuel S GiddingUNKNOWN American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascula
Dec 15, 2018·Current Opinion in Clinical Nutrition and Metabolic Care·Samuel S Gidding
Jul 14, 2017·Journal of Lipid Research·Andrew C MartinGerald F Watts
Mar 23, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Åsa GraumanLiisa Byberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.